People

  1. Fan
    Fan
  2. Myskowski
    Myskowski
  3. Juluru
    Juluru
  4. Mueller
    Mueller
  5. Hwang
    Hwang
  6. Zhong
    Zhong
  7. Cassileth
    Cassileth
  8. Deleon-Sanchez
    Deleon-Sanchez
  9. Chaudhari
    Chaudhari
  10. Rodriguez
    Rodriguez
  11. Wasmuth
    Wasmuth
  12. Elkin
    Elkin
  13. Lavallee
    Lavallee
  14. Nelson
    Nelson
  15. Tran
    Tran

Recent Works

  1. Patient-centered outcomes in ARIEL3, a phase 3, randomized, placebo-controlled study of rucaparib maintenance treatment in patients with recurrent ovarian carcinoma
    Meeting Abstract

    Bedel, D. J.; Lorusso, D.; Aghajanian, C.; Oaknin, A.; Dean, A.; Colombo, N.; Weberpals, J. I.; Clamp, A. R.; Scambia, G.; Leary, A.; more...
    Value in Health (2019)

    Fulltext@MSK | Save
  2. Cost-effectiveness of a 24-month fixed duration of venetoclax in combination with rituximab in relapsed or refractory chronic lymphocytic leukemia in the United States
    Meeting Abstract

    Huntington, S. F.; Strunz-McKendry, T.; Masaquel, A. S.; Shapouri, S.; Sail, K.; Durno, N.; Mato, A.
    Value in Health (2019)

    Fulltext@MSK | Save
  3. Quality adjusted time without symptoms of disease progression or toxicity (Q-TWIST) of nivolumab plus ipilimumab (NIVO+IPI) vs sunitinib (SUN) among untreated advanced renal cell carcinoma (ARCC) patients (patients) with intermediate or poor prognostic risk
    Meeting Abstract

    Shah, R.; Botteman, M.; Kwon, Y.; Gooden, K. M.; Cella, D.; Motzer, R.
    Value in Health (2019)

    Fulltext@MSK | Save